-
Top Stories: Ultragenyx Pharmaceutical Inc. (NASDAQ:RARE), JPMorgan Chase & Co. (NYSE:JPM), Ritchie Bros. Auctioneers Incorporated (NYSE:RBA), Analogic (NASDAQ:ALOG), State Auto Financial (NASDAQ:STFC)
On Monday shares of Ultragenyx Pharmaceutical Inc. (NASDAQ:RARE) closed at $60.95. MLV & Co. assumed coverage on shares of Ultragenyx Pharmaceutical (NASDAQ:RARE) in a report issued on Monday, TheFlyOnTheWall.com reports. The firm issued a buy rating on the stock. JPMorgan Chase & Co. (NYSE:JPM) in last trading activity advanced 2.37% to close at $60.96. Company…
-
Today’s Stocks: ConocoPhillips (NYSE:COP), Ultragenyx Pharmaceutical Inc. (NASDAQ:RARE), General Employment Enterprises Inc. (NYSEMKT:JOB), Unifi Inc. (NYSE:UFI), Tesla Motors Inc (NASDAQ:TSLA)
On Thursday shares of ConocoPhillips (NYSE:COP) closed at $62.76. Company’s sales growth for last 5 years was -18.90% and EPS growth for next 5 years is recorded as 0.52%. ConocoPhillips (NYSE:COP) Chairman and CEO Ryan Lance today testified to the benefits of lifting the outdated ban on U.S. crude oil exports. During his testimony, Lance…
-
Traders Are Watching: JinkoSolar Holding Co., (NYSE:JKS), Affimed N.V. (NASDAQ:AFMD), DeVry Education Group Inc. (NYSE:DV), Ultragenyx Pharmaceutical (NASDAQ:RARE), Telenav (NASDAQ:TNAV)
On Tuesday shares of JinkoSolar Holding Co., Ltd. (NYSE:JKS) closed at $24.30. Company’s sales growth for last 5 years was 26.50% and EPS growth for next 5 years is recorded as 11.00%. JinkoSolar Holding Co., Ltd. (NYSE:JKS), provided information in relation to a fire accident that occurred at one of its raw material processing workshops…
-
Worth Watching Stocks: Capnia (NASDAQ:CAPN), Ultragenyx Pharmaceutical Inc. (NASDAQ:RARE), American Electric Power Co., Inc. (NYSE:AEP), National American University (NASDAQ:NAUH), Yahoo! (NASDAQ:YHOO)
On Monday shares of Capnia, Inc. (NASDAQ:CAPN) closed at $6.28. On March 10, Capnia, Inc. (Nasdaq:CAPN) announced financial results for the fourth quarter and twelve months ended December 31, 2014. Net loss for the fourth quarter of 2014 was $7.9 million, or a loss of $2.23 per share, compared to a net loss of $1.0…
-
Stocks to Watch: ATRION Corp. (NASDAQ:ATRI), Facebook Inc (NASDAQ:FB), MeetMe (NASDAQ:MEET), Ultragenyx Pharmaceutical Inc. (NASDAQ:RARE), Institutional Financial Markets (NYSEMKT:IFMI)
Atrion Corp (NASDAQ: ATRI) declared a quarterly dividend of $0.75 per share, or $3 annualized. The dividend will be payable on March 31, 2015, to stockholders of record on March 17, 2015, with an ex-dividend date of March 13, 2015. On Wednesday shares of ATRION Corp. (NASDAQ:ATRI) closed at $326.15. Company’s sales growth for last…
-
Hot Watch List: Tesla Motors Inc (NASDAQ:TSLA), Cypress Energy Partners, L.P. (NYSE:CELP), AT&T (NYSE:T), Brooks Automation (NASDAQ:BRKS), Ultragenyx Pharmaceutical (NASDAQ:RARE)
Tesla Motors Inc (NASDAQ:TSLA) has filed a motion to intervene in a lawsuit filed last month by the Missouri Auto Dealers Association, entering themselves into the legal fray between the association and the state’s Department of Revenue. On Tuesday shares of Tesla Motors Inc (NASDAQ:TSLA) closed at $204.35. Company’s sales growth for last 5 years…
-
5 Stock in Different Moves: Cyberark Software Ltd (NASDAQ:CYBR), CenturyLink (NYSE:CTL), Ladenburg Thalmann Financial Services (NYSEMKT:LTS), Ultragenyx Pharmaceutical (NASDAQ:RARE), Netlist Inc. (NASDAQ:NLST)
Cyberark Software Ltd (NASDAQ:CYBR) announced Total revenue was $36.3 million, up 81% year-over-year compared with the fourth quarter of 2013. License revenue was $24.4 million, up 95% compared with the fourth quarter of 2013. Maintenance and Professional Services revenue was $11.9 million, up 57% year-over-year. On Thursday shares of Cyberark Software Ltd (NASDAQ:CYBR) closed at…
-
Stay on: Inovio Pharmaceuticals (NASDAQ:INO), SeaDrill Limited (NYSE:SDRL), Eastman Chemical Co. (NYSE:EMN), Amdocs Limited (NASDAQ:DOX), Ultragenyx Pharmaceutical Inc. (NASDAQ:RARE)
On 29 January, Inovio Pharmaceuticals, Inc. (NASDAQ:INO) announced it has appointed Mark Stephen Gelder, M.D. as Vice President, Clinical Development. Dr. Gelder will be responsible for planning and executing Inovio’s clinical development strategy for its immunotherapies against human papillomavirus (HPV)-caused cervical cancer and dysplasia. He will report to Dr. Mark Bagarazzi, Inovio’s Chief Medical Officer.…
-
Market Wrap Up: Full House Resorts Inc. (NASDAQ:FLL), GlobalSCAPE (NYSEMKT:GSB), Ultragenyx Pharmaceutical Inc. (NASDAQ:RARE), DepoMed Inc. (NASDAQ:DEPO), JAKKS Pacific (NASDAQ:JAKK)
On February 4, Full House Resorts, Inc. (NASDAQ:FLL) announced the appointment of Lewis Fanger as Senior Vice President, Chief Financial Officer and Treasurer. On Friday shares of Full House Resorts Inc. (NASDAQ:FLL) closed at $1.40. Company’s sales growth for last 5 years was 71.70% and EPS growth for next 5 years is recorded as 15.00%.…
-
Watch 5 Stocks: Lazard (NYSE:LAZ), Bank of America (NYSE:BAC), Jack Henry & Associates (NASDAQ:JKHY), Ultragenyx Pharmaceutical (NASDAQ:RARE), Just Energy Group (NYSE:JE)
Lazard Ltd. (NYSE:LAZ) reported better-than-expected earnings for the fourth quarter. The Hamilton, Bermuda-based company posted quarterly earnings of $172.4 million, or $1.29 per share, compared to $53.2 million, or $0.40 per share, in the year-ago period. Its net revenue climbed 3.5% to $633.9 million. However, analysts were expecting earnings of $1.06 per on revenue of…